Subgroups that combine IL-10 or IL-6 with NEWS or SIRS scores could further help identify high-risk individuals who may develop sepsis or require intensive care, allowing clinicians to further help guide treatment. This evidence concerns the gene IL6 and systemic inflammatory response syndrome.